Ligand · KE9
KE9 · (E)-3-(3,5-difluoro-4-((1R,3R)-2-(2-fluoro-2- methylpropyl)-3-methyl-2,3,4,9-tetrahydro-1H-pyrido(3,4-b)indol-1-yl)phenyl)acrylic acid
KE9, (E)-3-(3,5-difluoro-4-((1R,3R)-2-(2-fluoro-2- methylpropyl)-3-methyl-2,3,4,9-tetrahydro-1H-pyrido(3,4-b)indol-1-yl)phenyl)acrylic acid (C25 H25 F3 N2 O2, 442.5 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB…
- Component
- KE9
- Formula
- C25 H25 F3 N2 O2
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
KE9 in 2 structures; the first of them:
- 5ACC · A Novel Oral Selective Estrogen Receptor Down-regulator, AZD9496, drives Tumour Growth… · KE9 A1546 · binds MET343, LEU346, THR347, LEU349, ALA350, ASP351, GLU353, TRP383 and 15 more
- 5ACC · A novel oral selective estrogen receptor down-regulator, AZD9496, drives tumour growth… · KE9 A1546 · binds MET343, LEU346, THR347, LEU349, ALA350, ASP351, GLU353, TRP383 and 15 more
Residues it binds most
LEU 2, MET 2, PHE 2, ALA 2, ARG 2, ASP 2, GLU 2, GLY 2, HIS 2, ILE 2 (residue and the binding sites it lines).
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.